Accera, University of Miami to study Axona for cognitive impairment in MS

Wednesday, April 10, 2013

Accera, a privately-held, commercial-stage healthcare company focused on clinical applications to address acute and chronic neurodegenerative diseases, has formed a collaboration with the University of Miami Miller School of Medicine to study the effects of Accera’s medical food, Axona, on cognitive impairment in patients with multiple sclerosis (MS).

[Read More]